SCHEDULE OF OUTSTANDING STOCK WARRANTS ACTIVITIES (Details) - $ / shares |
12 Months Ended | |
|---|---|---|
Dec. 31, 2021 |
Dec. 31, 2020 |
|
| Equity [Abstract] | ||
| Number of warrants, beginning balance | 800 | 800 |
| Weighted average exercise price, beginning balance | $ 300.00 | $ 300.00 |
| Weighted average remaining contractual Llfe (Years), ending balance | 1 year 4 months 13 days | 2 years 4 months 13 days |
| Number of warrants, granted | 3,456,000 | |
| Weighted average exercise price, granted | ||
| Number of warrants, exercised | (925,908) | |
| Weighted average exercise price, exercised | ||
| Number of warrants, Forfeited | ||
| Weighted average exercise price, forfeited | ||
| Number of warrants, Cancelled | (800) | |
| Weighted average exercise price, cancelled | ||
| Number of warrants, ending balance | 2,530,092 | 800 |
| Weighted average exercise price, ending balance | $ 5.00 | $ 300.00 |
| Weighted average remaining contractual Llfe (Years), ending balance | 4 years 5 months 1 day | 1 year 4 months 13 days |
| X | ||||||||||
- Definition Weighted average exercise price, Beginning balance. No definition available.
|
| X | ||||||||||
- Definition Weighted average exercise price, Exercised. No definition available.
|
| X | ||||||||||
- Definition Share based compensation arrangements by share based payment award non options expirations in period weighted average exercise price. No definition available.
|
| X | ||||||||||
- Definition Weighted average exercise price, Forfeited. No definition available.
|
| X | ||||||||||
- Definition Weighted average exercise price, Granted. No definition available.
|
| X | ||||||||||
- Definition Weighted average remaining contractual life (Years), Beginning Balance. No definition available.
|
| X | ||||||||||
- Definition Weighted Average Remaining Contractual Life (Years), Ending Balance. No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Number of non-option equity instruments exercised by participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of shares under non-option equity instrument agreements for which rights to exercise lapsed. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of shares under non-option equity instrument agreements that were cancelled as a result of occurrence of a terminating event. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Net number of non-option equity instruments granted to participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of equity instruments other than options outstanding, including both vested and non-vested instruments. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|